Journal article · 2024 · Open access

Apolipoprotein E and Apolipoprotein E receptor 2 signaling as drug targets in Alzheimer’s disease

Abdel Ali Belaidi, Ashley Ian Bush, Scott Ayton

Alzheimer s & Dementia, 20(S1), e086014 · Published 1 December 2024 · DOI 10.1002/alz.086014

Open PDFView at the publisherCite this paper

In brief

“Apolipoprotein E and Apolipoprotein E receptor 2 signaling as drug targets in Alzheimer’s disease” is a 2024 journal article by Abdel Ali Belaidi and 2 co-authors, published in Alzheimer s & Dementia. OpenAlex counts 1 citations as of 18 November 2026. It is open access under a CC BY licence: the full text is free to read at Alzheimer s & Dementia.

Citations
1
Most cited in
2025 (1)
Field-weighted impact
0.13
Authors
3

Abstract

BACKGROUND: Allelic variation in apolipoprotein E (APOE) is by far the greatest contributor to Alzheimer's disease (AD) after age, but the mechanisms underlying how APOE impacts on the pathology of AD remain undefined. While most research is focusing on mechanisms associated with the presence of the APOE risk allele, several aspects of APOE biology remain poorly understood. In particular, the physiological relevance of APOE receptors and their impact on disease progression have been overlooked. METHOD: Ferroptosis was induced in N27 neurons using multiple agents (erastin, RSL3) and toxicity was evaluated using different viability assays (MTT, Propidium iodide, LDH) and ferroptosis. N27 neurons were transfected with a plasmid encoding APOER2-GFP fusion protein or a GFP-expressing control vector, while recombinantly expressed and purified APOE was used as an APOE source. RESULT: Here, we present data supporting a function of APOE in tandem with APOER2 in protecting neurons from ferroptosis. Ferroptosis is a cell death pathway characterized by the accumulation of lethal lipid hydroperoxides resulting from iron-dependent oxidation of polyunsaturated fatty acids. APOER2 expression in neurons resulted in increase in glutathione peroxidase 4 (GPX4) expression, which functions by converting toxic lipid peroxides into non-toxic lipid alcohol and thus increases resistance to ferroptosis. We further report that APOER2 expression potentiates APOE-mediated protection from ferroptotic cell death in in N27 neurons. Further mechanistic studies are ongoing to validate the underlying mechanism and the involved signaling cascades. CONCLUSION: We present evidence for the involvement of APOE and APOER2 in neuronal protection from ferroptotic cell death. These findings represent new drug targets that can be explored to slowdown neurodegeneration in AD. FUNDING: This study was supported by grants from the Alzheimer's Association and National Health & Medical Research Council of Australia.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Belaidi, A. A., Bush, A. I., & Ayton, S. (2024). Apolipoprotein E and Apolipoprotein E receptor 2 signaling as drug targets in Alzheimer’s disease. Alzheimer s & Dementia, 20(S1), e086014. https://doi.org/10.1002/alz.086014

MLA 9

Belaidi, Abdel Ali, et al. “Apolipoprotein E and Apolipoprotein E receptor 2 signaling as drug targets in Alzheimer’s disease.” Alzheimer s & Dementia, vol. 20, no. S1, 2024, p. e086014. https://doi.org/10.1002/alz.086014.

Chicago

Belaidi, Abdel Ali, Ashley Ian Bush, and Scott Ayton. 2024. “Apolipoprotein E and Apolipoprotein E receptor 2 signaling as drug targets in Alzheimer’s disease.” Alzheimer s & Dementia 20 (S1): e086014. https://doi.org/10.1002/alz.086014.

Harvard

Belaidi, A. A., Bush, A. I. and Ayton, S. (2024) ‘Apolipoprotein E and Apolipoprotein E receptor 2 signaling as drug targets in Alzheimer’s disease’, Alzheimer s & Dementia, 20(S1), p. e086014. doi:10.1002/alz.086014.

IEEE

A. A. Belaidi, A. I. Bush, and S. Ayton, “Apolipoprotein E and Apolipoprotein E receptor 2 signaling as drug targets in Alzheimer’s disease,” Alzheimer s & Dementia, vol. 20, no. S1, p. e086014, 2024, doi: 10.1002/alz.086014.

BibTeX

@article{belaidi2024apolipoprotein,
  title     = {{Apolipoprotein E and Apolipoprotein E receptor 2 signaling as drug targets in Alzheimer’s disease}},
  author    = {Belaidi, Abdel Ali and Bush, Ashley Ian and Ayton, Scott},
  journal   = {Alzheimer s \& Dementia},
  year      = {2024},
  volume    = {20},
  number    = {S1},
  pages     = {e086014},
  doi       = {10.1002/alz.086014},
  url       = {https://doi.org/10.1002/alz.086014}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments

  • apolipoprotein E

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Belaidi, A. A., Bush, A. I., & Ayton, S. (2024). Apolipoprotein E and Apolipoprotein E receptor 2 signaling as drug targets in Alzheimer’s disease. Alzheimer s & Dementia, 20(S1), e086014. https://doi.org/10.1002/alz.086014

How many times has this paper been cited?

1 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Alzheimer s & Dementia: sign in and open the PDF from this page.

Who wrote this paper?

Abdel Ali Belaidi, Ashley Ian Bush, Scott Ayton.

What is the DOI of this paper?

10.1002/alz.086014, permanently at https://doi.org/10.1002/alz.086014. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.